Kuiper Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Kuiper General Information

Description

Provider of regulatory consulting services intended for pre-clinical and clinical development of cell and gene therapies. The company provides stem cell therapy for vascular deficits such as chronic limb ischemia and coronary microvascular dysfunction along with various services, enabling the healthcare industry to facilitate strategy development of various applied cell therapies.

Contact Information

Website
www.kuiperinc.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 251 Little Falls Drive
  • Wilmington, DE 19808
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • 251 Little Falls Drive
  • Wilmington, DE 19808
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kuiper Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 11-Apr-2022 Completed Out of Business
1. Seed Round 13-Aug-2019 Completed Clinical Trials - General
To view Kuiper’s complete valuation and funding history, request access »

Kuiper Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Kuiper’s complete cap table history, request access »

Kuiper Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Kuiper Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4509137-A1 A chimeric antigen receptor combinatorial multi-antigen targeted allogeneic t cell immunotherapy with reduced risk of t cell exhaustion, host versus graft rejection, and graft versus host disease Pending 14-Jun-2023

Ready to get started?

Request a free trial

Kuiper FAQs

  • Where is Kuiper headquartered?

    Kuiper is headquartered in Wilmington, DE.

  • What industry is Kuiper in?

    Kuiper’s primary industry is Drug Discovery.

  • Is Kuiper a private or public company?

    Kuiper is a Private company.

  • What is Kuiper’s current revenue?

    The current revenue for Kuiper is .

  • How much funding has Kuiper raised over time?

    Kuiper has raised $250K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process